Nigeria’s healthcare sector is once again under scrutiny as experts warn that the country’s continued dependence on imported medicines is weakening both healthcare delivery and economic growth.
According to industry stakeholders, Nigeria still imports more than 70 percent of its drugs and medical supplies despite being Africa’s largest economy and one of the continent’s most populated nations. The situation has raised concerns among healthcare professionals, pharmaceutical manufacturers, and economists who believe the country is exposing itself to avoidable risks.
For years, Nigeria has struggled with unstable drug prices, shortages of essential medicines, and foreign exchange pressures. Analysts say the heavy reliance on imports has made these problems worse, especially during periods of global supply chain disruption and currency instability.
Why Experts Are Concerned
Healthcare experts argue that depending heavily on imported drugs leaves Nigeria vulnerable during international crises. During the COVID-19 pandemic, many countries prioritized their own medical needs, making it difficult for nations like Nigeria to access essential supplies quickly.
Industry leaders believe the lesson from that period should have pushed Nigeria toward stronger local pharmaceutical production. Instead, the country still depends largely on medicines produced abroad, mainly from India and China.
Experts also warn that fluctuations in the value of the naira continue to increase the cost of imported medicines. As the naira weakens against foreign currencies, pharmaceutical companies spend more money importing raw materials and finished products, costs that are eventually transferred to consumers.
For many Nigerians already dealing with economic hardship, this has made healthcare increasingly expensive.
The State of Local Manufacturing
Nigeria does have local pharmaceutical companies, but many operate below full capacity due to several long standing challenges.
Manufacturers often complain about poor electricity supply, high production costs, inadequate infrastructure, and limited access to financing. Some also point to inconsistent government policies and excessive dependence on imported raw materials needed for drug production.
Experts say local companies cannot compete effectively with cheaper imported products unless the government creates a more supportive environment for manufacturing.
Stakeholders are now calling for policies that would encourage investment in local pharmaceutical production, including tax incentives, easier access to credit, stable power supply, and stronger government patronage of locally made drugs.
A National Security Issue
Beyond economics, analysts increasingly describe drug manufacturing as a national security matter.
Countries with strong local pharmaceutical industries are better positioned to respond during emergencies, pandemics, or global supply disruptions. Nigeria’s current dependence, experts argue, leaves the nation exposed whenever international markets face instability.
There are also concerns about counterfeit medicines entering the country through weak import monitoring systems. Strengthening local production, experts say, could improve quality control and regulatory oversight.
What Needs to Change
Industry stakeholders believe Nigeria must move from talking about industrialization to actively supporting it.
They argue that healthcare should not rely almost entirely on foreign supply chains when the country has the population, market size, and workforce needed to build a stronger pharmaceutical sector.
Some experts are also urging the government to invest more in research, pharmaceutical education, and partnerships between universities and manufacturers. Others believe regional trade agreements across Africa could help Nigerian drug makers expand production and compete continentally.
While reforms may take time, many believe reducing dependence on imported medicines is necessary if Nigeria hopes to strengthen both its healthcare system and industrial economy.
For now, the debate continues, but one thing is becoming increasingly clear: Africa’s largest nation may no longer be able to afford relying on the rest of the world for most of its medicines.
Read More https://www.theprojectherald.com/world-bank-cancels-717m-nigeria-power-funding-explained/